AUTH:"Juraska M" - Search results

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, [...] United States Government (USG)/CoVPN Biostatistics Team

Nat Commun, 15(1):9785, 12 Nov 2024

Cited by: 0 articles | PMID: 39532861 | PMCID: PMC11557889

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Hesselman MC, Zeeb M, Rusert P, Pasin C, Mamrosh J, Kariuki S, Sickmann M, Kaufmann MM, Schmidt D, Friedrich N, Metzner KJ, Rindler A, Kuster H, Adams C, Thebus R, Huber M, Yerly S, Leuzinger K, Perreau M, [...] Trkola A

bioRxiv, 10 Sep 2024

Cited by: 0 articles | PPR: PPR908431

Add to export list Preprint

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Gray GE, Mngadi K, Lavreys L, Nijs S, Gilbert PB, Hural J, Hyrien O, Juraska M, Luedtke A, Mann P, McElrath MJ, Odhiambo JA, Stieh DJ, van Duijn J, Takalani AN, Willems W, Tapley A, Tomaras GD, Van Hoof J, [...] Imbokodo/HVTN 705/HPX2008 Study Group

Lancet Infect Dis, 24(11):1201-1212, 19 Jul 2024

Cited by: 2 articles | PMID: 39038477

Add to export list

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.

Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O, [...] Imbokodo Study and Correlates Group

EBioMedicine, 108:105320, 04 Sep 2024

Cited by: 0 articles | PMID: 39236556 | PMCID: PMC11404224

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Genotypic analysis of RTS,S/AS01_E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.

Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser D, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PBY, English S, Fitzgerald N, [...] Neafsey DE

Lancet Infect Dis, 24(9):1025-1036, 06 May 2024

Cited by: 1 article | PMID: 38723650 | PMCID: PMC11339203

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, [...] Gilbert PB

Nat Commun, 15(1):2175, 11 Mar 2024

Cited by: 2 articles | PMID: 38467646 | PMCID: PMC10928100

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Reeves DB, Mayer BT, deCamp AC, Huang Y, Zhang B, Carpp LN, Magaret CA, Juraska M, Gilbert PB, Montefiori DC, Bar KJ, Cardozo-Ojeda EF, Schiffer JT, Rossenkhan R, Edlefsen P, Morris L, Mkhize NN, Williamson C, Mullins JI, [...] Edupuganti S

Nat Commun, 15(1):2575, 22 Mar 2024

Cited by: 0 articles | PMID: 38519455 | PMCID: PMC10959920

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.

Huang Y, Zhang L, Karuna S, Andrew P, Juraska M, Weiner JA, Angier H, Morgan E, Azzam Y, Swann E, Edupuganti S, Mgodi NM, Ackerman ME, Donnell D, Gama L, Anderson PL, Koup RA, Hural J, Cohen MS, [...] Lemos MP

Nat Commun, 14(1):7813, 28 Nov 2023

Cited by: 2 articles | PMID: 38016958 | PMCID: PMC10684488

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Reeves DB, Mayer BT, deCamp AC, Huang Y, Zhang B, Carpp LN, Magaret CA, Juraska M, Gilbert PB, Montefiori DC, Bar KJ, Cardozo-Ojeda EF, Schiffer JT, Rossenkhan R, Edlefsen P, Morris L, Mkhize NN, Williamson C, Mullins JI, [...] Edupuganti S

Nat Commun, 14(1):8299, 14 Dec 2023

Cited by: 1 article | PMID: 38097552 | PMCID: PMC10721814

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

Juraska M, Bai H, deCamp AC, Magaret CA, Li L, Gillespie K, Carpp LN, Giorgi EE, Ludwig J, Molitor C, Hudson A, Williamson BD, Espy N, Simpkins B, Rudnicki E, Shao D, Rossenkhan R, Edlefsen PT, Westfall DH, [...] Mullins JI

Proc Natl Acad Sci U S A, 121(4):e2308942121, 19 Jan 2024

Cited by: 4 articles | PMID: 38241441 | PMCID: PMC10823214

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy

Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser DA, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PB, English S, Fitzgerald N, [...] Neafsey DE

medRxiv, 23 Nov 2023

Cited by: 0 articles | PPR: PPR764275

Add to export list Preprint

Violence Exposure Among Women in the Sex Industry and Their Children in El Alto, Bolivia: A Comparative Cross-Sectional Study.

Antkowiak L, Boynton-Jarrett R, Chiang SS, Castellon D, Gilbert PB, Juraska M, Sox CM, Huang CC

Violence Vict, 38(5):736-753, 12 Oct 2023

Cited by: 0 articles | PMID: 37827582

Add to export list

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.

Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Asante KP, Bhate AS, Beresnev T, Bonaparte MI, Celle M, Ceregido MA, Corey L, Dobrianskyi D, Fu B, Grillet MH, Keshtkar-Jahromi M, Juraska M, [...] VAT00008 Study Team

Lancet Respir Med, 11(11):975-990, 13 Sep 2023

Cited by: 8 articles | PMID: 37716365 | PMCID: PMC10872639

Add to export list Free full text in Europe PMC

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Bhate AS, Beresnev T, Bonaparte MI, Celle M, Ceregido MA, Corey L, Fu B, Grillet MH, Keshtkar-Jahromi M, Juraska M, Kee JJ, Kaali S, [...] VAT00008 study team

EClinicalMedicine, 64:102168, 12 Sep 2023

Cited by: 2 articles | PMID: 37936652 | PMCID: PMC10626161

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.

Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, [...] Tomaras GD

EBioMedicine, 93:104590, 08 Jun 2023

Cited by: 10 articles | PMID: 37300931 | PMCID: PMC10363420

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Magaret C, Li L, deCamp A, Rolland M, Juraska M, Williamson B, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Carpp L, Bai H, Dearlove B, Greninger A, Roychoudhury P, Sadoff J, Gray G, Roels S, [...] Gilbert P

Research Square, 31 May 2023

Cited by: 0 articles | PPR: PPR668364

Add to export list Preprint v1

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine

Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Asante KP, Suresh Bhate A, Beresnev T, Bonaparte MI, Angeles Ceregido M, Dobrianskyi D, Fu B, Grillet M, Keshtkar-Jahromi M, Juraska M, Jin Kee J, Kibuuka H, [...] the VAT00008 study team

medRxiv, 06 Dec 2022

Cited by: 0 articles | PPR: PPR581452

Add to export list Preprint

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.

Qi L, Sun Y, Juraska M, Moodie Z, Magaret CA, Heng F, Carpp LN, Gilbert PB

Vaccine, 40(41):5912-5923, 05 Sep 2022

Cited by: 0 articles | PMID: 36068106 | PMCID: PMC9881745

Add to export list Free full text in Europe PMC

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Gilbert PB, Huang Y, deCamp AC, Karuna S, Zhang Y, Magaret CA, Giorgi EE, Korber B, Edlefsen PT, Rossenkhan R, Juraska M, Rudnicki E, Kochar N, Huang Y, Carpp LN, Barouch DH, Mkhize NN, Hermanus T, Kgagudi P, [...] Morris L

Nat Med, 28(9):1924-1932, 22 Aug 2022

Cited by: 42 articles | PMID: 35995954 | PMCID: PMC9499869

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.

Takuva S, Karuna ST, Juraska M, Rudnicki E, Edupuganti S, Anderson M, De La Grecca R, Gaudinski MR, Sehurutshi A, Orrell C, Naidoo L, Valencia J, Villela LM, Walsh SR, Andrew P, Karg C, Randhawa A, Hural J, Gomez Lorenzo MM, [...] HVTN 703/HPTN 081 and HVTN 704/HPTN 085 Study Teams

J Acquir Immune Defic Syndr, 89(4):405-413, 01 Apr 2022

Cited by: 6 articles | PMID: 34923559 | PMCID: PMC9555144

Add to export list Free full text in Europe PMC

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand.

Thomas R, Chansinghakul D, Limkittikul K, Gilbert PB, Hattasingh W, Moodie Z, Shangguan S, Frago C, Dulyachai W, Li SS, Jarman RG, Geretz A, Bouckenooghe A, Sabchareon A, Juraska M, Ehrenberg P, Michael NL, Bailleux F, Bryant C, Gurunathan S

Hum Immunol, 83(1):53-60, 08 Oct 2021

Cited by: 4 articles | PMID: 34635391 | PMCID: PMC10536818

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.

Huang Y, Zhang L, Eaton A, Mkhize NN, Carpp LN, Rudnicki E, DeCamp A, Juraska M, Randhawa A, McDermott A, Ledgerwood J, Andrew P, Karuna S, Edupuganti S, Mgodi N, Cohen M, Corey L, Mascola J, Gilbert PB, [...] Montefiori DC

Hum Vaccin Immunother, 18(1):1908030, 02 Jul 2021

Cited by: 6 articles | PMID: 34213402 | PMCID: PMC8928800

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries.

Huang Y, Moodie Z, Juraska M, Fong Y, Carpp LN, Chambonneau L, Coronel DL, Dayan GH, DiazGranados CA, Gilbert PB

Trans R Soc Trop Med Hyg, 115(7):750-763, 01 Jul 2021

Cited by: 2 articles | PMID: 33369671 | PMCID: PMC8245293

Add to export list Free full text in Europe PMC

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.

Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, [...] HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams

N Engl J Med, 384(11):1003-1014, 01 Mar 2021

Cited by: 234 articles | PMID: 33730454 | PMCID: PMC8189692

Add to export list Free full text in Europe PMC

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.

Huang Y, Naidoo L, Zhang L, Carpp LN, Rudnicki E, Randhawa A, Gonzales P, McDermott A, Ledgerwood J, Lorenzo MMG, Burns D, DeCamp A, Juraska M, Mascola J, Edupuganti S, Mgodi N, Cohen M, Corey L, Andrew P, [...] Lazarus E

EBioMedicine, 64:103203, 23 Jan 2021

Cited by: 13 articles | PMID: 33493795 | PMCID: PMC7841500

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial.

Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study.

Genotypic analysis of RTS,S/AS01_E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy

Violence Exposure Among Women in the Sex Industry and Their Children in El Alto, Bolivia: A Comparative Cross-Sectional Study.

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand.

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.

Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countries.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.

Partnerships & funding